FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Partners: Hôpitaux Universitaires de Genève – (UniGE)

The organisation

UniGEThe University of Geneva is an institution devoted to research, teaching and dialogue. It is the site of academic creativity and the transmission of knowledge.

Since its foundation in 1559 the UNIGE has developed ever higher ethical standards and steadily increased in quality and the will to innovation. Today it is one of Europe’s leading universities.

The UNIGE also shares the international calling of its host city, Geneva, a centre of international and multicultural activities with a venerable cosmopolitan tradition. Its desire to expand its collaboration with partner institutions and broaden its appeal to researchers and students from around the world has made the UNIGE a "globalised university", a meeting place for academic disciplines and various cultures, and a forum for ideas.

The University of Geneva Hospitals (HUG), hosts a 2,200-bed health care center providing primary and tertiary care for Geneva and its surrounding community. The institution consists of acute care facilities offering all medical specialities of a tertiary care centre including several transplant services and as well as long-term care facilities for the elderly and patients requiring chronic care. HUG hosts several experts (Profs. Harbarth, Pittet and Schrenzel) who have generated ground-breaking articles in the field of antibiotic resistance and infection control. This team will guarantee that the SATURN study will be coordinated and supervised successfully. The investigators are already co-ordinating or participating in several international EC-funded projects (MOSAR, CHAMP, MagRSA, Prohibit).

Key staff involved in the project

Stephan HarbarthProf. Stephan Harbarth (MD, MS) is the scientist in charge of the coordination of SATURN and the supervision of WP3. He is a well-known infectious disease epidemiologist with extensive research experience in the field of antimicrobial use and resistance. In the past, he has devoted substantial efforts toward control of resistance through improved antibiotic use. He was recipient of the Holtzer-Scholarship from Harvard University for postgraduate studies at Harvard School of Public Health in 1998-99 (M.S. in Epidemiology), recipient of the Young Investigator Awards by the Swiss Society of Infectious Diseases, the European Society of Microbiology and Infectious Diseases and the American Society of Microbiology for research excellence and scientific promise. He is currently associated professor in medicine, hospital epidemiologist, senior consultant in infectious diseases, with more than 70 original articles in peer-reviewed journals as 1st, 2nd or last author.

Didier PittetProf. Didier Pittet (MD, MS) is an internationally recognised opinion leader in the field of infection control and has published more than 300 original articles in peer-reviewed journals. In particular, he is an expert in the epidemiology of nosocomial infections, involved in a number of national and international scientific collaborations. He is chairperson of the 2005-2006 “Global Patient Safety Challenge”, a major component of the WHO World Alliance for Patient Safety.

Jacques SchrenzelDr. Jacques Schrenzel (MD) is medical microbiologist and director of the bacteriology laboratory and head of the genomic research laboratory (www.genomic.ch) at UniGE. He is coordinator of the STREP program MagRSA dedicated to the development of a POCT system for MRSA screening. He is also WP1 leader of the COST Action B28 on microarrays for BSL3 and BSL4 pathogens. His work focuses on the study of bacterial resistance and pathogenesis at the genomic level.

Further information

Prof. Stephan Harbarth, MD, MS
Infection Control Program
University of Geneva Hospitals and Medical Faculty
4 Rue Gabrielle Perret-Gentil,
CH-1211 Geneva 14 - Switzerland
Phone: (+41) 22 372 9828
Fax: (+41) 22 372 3987


Top ^